aTyr Pharma Inc
NASDAQ:ATYR

Watchlist Manager
aTyr Pharma Inc Logo
aTyr Pharma Inc
NASDAQ:ATYR
Watchlist
Price: 3.91 USD -1.51%
Market Cap: 328.2m USD
Have any thoughts about
aTyr Pharma Inc?
Write Note

P/OCF
Price to OCF

-4.9
Current
-4.7
Median
21.6
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-4.9
=
Market Cap
328.2m USD
/
Operating Cash Flow
-67m USD
All Countries
Close
Market Cap P/OCF
US
aTyr Pharma Inc
NASDAQ:ATYR
328.2m USD -4.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -240 114.6
US
Abbvie Inc
NYSE:ABBV
315.6B USD 19.1
US
Amgen Inc
NASDAQ:AMGN
140.4B USD 19.4
US
Gilead Sciences Inc
NASDAQ:GILD
113.3B USD 11.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.2B USD -124.8
US
Epizyme Inc
F:EPE
94.1B EUR -468.5
AU
CSL Ltd
ASX:CSL
138.1B AUD 31.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
80.2B USD 18.9
US
Seagen Inc
F:SGT
39.3B EUR -75.6
NL
argenx SE
XBRU:ARGX
37.3B EUR -149.4
 
US
aTyr Pharma Inc
NASDAQ:ATYR
Average P/OCF: 20
Negative Multiple: -4.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -240 114.6
US
Abbvie Inc
NYSE:ABBV
19.1
US
Amgen Inc
NASDAQ:AMGN
19.4
US
Gilead Sciences Inc
NASDAQ:GILD
11.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -124.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -468.5
AU
CSL Ltd
ASX:CSL
31.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -75.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -149.4

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A